Associations of Lactoferrin-Fortified Formula with Infant Growth and Gut Microbiota: A Real-World Observational Study
Nutrients · 2025
DOI: 10.3390/nu17243896 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2025. Verfasst von Xiaojin Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vanke School of Public Health, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lactoferrin, Infant Formula, Child Development. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background/Objectives: Lactoferrin, a key bioactive component in human milk, may bridge functional gaps in infant formula; however, its long-term effects on growth and the gut microbiota in term infants remain underexplored, particularly in real-world settings.
Methods
This real-world evidence (RWE) study assessed the impact of lactoferrin-fortified formula (LF) on infant growth, the gut microbiota, and feeding tolerance compared with control formula (CF) and exclusive breastfeeding (BF). After propensity score matching (PSM) for maternal education level and infant age, 111 matched Chinese infants (37 per group: LF, CF, and BF; age: 6–12 months) were analyzed. Growth was evaluated using WHO Z-scores (WAZ, LAZ, WLZ, and zBMI). The gut microbiota was profiled via 16S rRNA sequencing (n = 81). Feeding challenges were quantified using the Montreal Children’s Hospital Feeding Scale (MCH-FS).
Results
The LF group exhibited significantly higher length-for-age Z-scores (LAZ) compared with both the BF and CF groups (p < 0.001), indicating superior linear growth. LF infants also showed reduced MCH-FS scores (18.0 vs. 36.2 in CF; p < 0.001), signifying fewer feeding difficulties. Gut microbiota analysis revealed enrichment of Bifidobacterium breve and butyrate-producing taxa (e.g., Faecalibacterium and Ruminococcaceae), higher alpha diversity, and metabolic divergence, involving enhanced lysine fermentation to acetate/butyrate in LF infants, suggesting a higher level of short-chain fatty acid (SCFA) production. Beta diversity analysis demonstrated that the LF microbiota clustered close to BF.
Conclusions
Lactoferrin-fortified formula was associated with improved linear growth and feeding tolerance while shaping a healthy gut microbiota, showing similarities to breastfed infants’ microbiota. These findings support LF fortification as a strategy to improve functional outcomes in formula-fed infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanke School of Public Health, Tsinghua University, Beijing 100084, China.
- Inner Mongolia Dairy Technology Research Institute Co., Ltd., Hohhot 010110, China.
- College of Food Science and Engineering, Changchun University, Changchun 130022, China.
- Institute for Healthy China, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Xiaojin Shi, Ai Zhao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Shi, X., Liu, B., Ye, W., Qi, X., Xi, M., Liu, S., Zhu, Q., Zheng, L., & Zhao, A. (2025). Associations of Lactoferrin-Fortified Formula with Infant Growth and Gut Microbiota: A Real-World Observational Study. Nutrients. https://doi.org/10.3390/nu17243896
Vancouver
Shi X, Liu B, Ye W, Qi X, Xi M, Liu S, et al. Associations of Lactoferrin-Fortified Formula with Infant Growth and Gut Microbiota: A Real-World Observational Study. Nutrients. 2025. doi:10.3390/nu17243896
BibTeX
@article{Shi2025,
author = {Shi, Xiaojin and Liu, Biao and Ye, Wenhui and Qi, Xuanjing and Xi, Menglu and Liu, Shuqi and Zhu, Qihan and Zheng, Lutong and Zhao, Ai},
title = {Associations of Lactoferrin-Fortified Formula with Infant Growth and Gut Microbiota: A Real-World Observational Study},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17243896}
}
EUVIMED